Fresh analysis indicates that individuals who come off new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Findings released in a leading medical journal demonstrates that while overweight individuals can lose about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such treatments should be cognizant of the risk of fast rebound weight gain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain implies a reversion to original mass within about one and a half years.
Analyzing Therapies
The analysis, which reviewed 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with other pills.
Scientists point out that people who lose weight through lifestyle changes alone typically experience a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Regain
Doctors propose the mode of action of the jabs is key to understanding the amplified rebound.
These medications mimic a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' leads to hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Issue?
The NHS suggest the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts contend that, due to the significant potential of relapse, the therapy should be considered long-term.
This perspective is supported by drug manufacturers, who note that the findings "highlight the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
Patient Accounts
Individuals who have stopped the medication describe a intense return of hunger.
"It felt as if a switch flipping and you become ravenous," described an individual.
The struggle is exacerbated if users have not developed lasting lifestyle or habit changes during treatment.
Widespread Adoption
Recent estimates indicate that a significant number of people in the UK have tried these injections in the past year, with desire remaining high.
- Use is greater among women than men.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while the jabs are effective agents for weight loss, they are not a magic solution and maintained weight loss likely depends on ongoing behavioural management.
